Skip to Main Content

Paper Details

Patient-tailored design for selective co-inhibition of leukemic cell subpopulations.
Sci Adv
18
2021
Author NameAffiliation
Krister WennerbergInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Krister WennerbergBiotech Research and Innovation Centre (BRIC) and Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen
Tero AittokallioInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Tero AittokallioHelsinki Institute for Information Technology (HIIT), Aalto University
Tero AittokallioInstitute for Cancer Research, Oslo University Hospital
Tero AittokallioUniversity of Oslo
  • 1 - 6

Datasets